Direct presentation of inflammation-associated self-antigens by thymic innate-like T cells induces elimination of autoreactive CD8+ thymocytes
- PMID: 38992254
- PMCID: PMC11291280
- DOI: 10.1038/s41590-024-01899-6
Direct presentation of inflammation-associated self-antigens by thymic innate-like T cells induces elimination of autoreactive CD8+ thymocytes
Abstract
Upregulation of diverse self-antigens that constitute components of the inflammatory response overlaps spatially and temporally with the emergence of pathogen-derived foreign antigens. Therefore, discrimination between these inflammation-associated self-antigens and pathogen-derived molecules represents a unique challenge for the adaptive immune system. Here, we demonstrate that CD8+ T cell tolerance to T cell-derived inflammation-associated self-antigens is efficiently induced in the thymus and supported by redundancy in cell types expressing these molecules. In addition to thymic epithelial cells, this included thymic eosinophils and innate-like T cells, a population that expressed molecules characteristic for all major activated T cell subsets. We show that direct T cell-to-T cell antigen presentation by minute numbers of innate-like T cells was sufficient to eliminate autoreactive CD8+ thymocytes. Tolerance to such effector molecules was of critical importance, as its breach caused by decreased thymic abundance of a single model inflammation-associated self-antigen resulted in autoimmune elimination of an entire class of effector T cells.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Kyewski, B. & Derbinski, J. Self-representation in the thymus: an extended view. Nat. Rev. Immunol.4, 688–698 (2004). - PubMed
-
- Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the AIRE protein. Science298, 1395–1401 (2002). - PubMed
-
- Takaba, H. et al. Fezf2 orchestrates a thymic program of self-antigen expression for immune tolerance. Cell163, 975–987 (2015). - PubMed
MeSH terms
Substances
Grants and funding
- 21 1602 Pj/Cancerfonden (Swedish Cancer Society)
- PR2021-017/Barncancerfonden (Swedish Childhood Cancer Foundation)
- PR2023-0091/Barncancerfonden (Swedish Childhood Cancer Foundation)
- 211192/Radiumhemmets Forskningsfonder (Cancer Research Foundations of Radiumhemmet)
- 231233/Radiumhemmets Forskningsfonder (Cancer Research Foundations of Radiumhemmet)
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
